2.86
7.30%
0.19
시간 외 거래:
2.79
-0.07
-2.45%
전일 마감가:
$2.67
열려 있는:
$2.76
하루 거래량:
538.18K
Relative Volume:
1.24
시가총액:
$62.64M
수익:
$156.31M
순이익/손실:
$-245.76M
주가수익비율:
-3.3647
EPS:
-0.85
순현금흐름:
$-234.16M
1주 성능:
+3.43%
1개월 성능:
-36.33%
6개월 성능:
-74.24%
1년 성능:
-78.96%
아제너스 Stock (AGEN) Company Profile
명칭
Agenus Inc
전화
781-674-4410
주소
3 FORBES ROAD, LEXINGTON, MA
AGEN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AGEN | 2.86 | 62.64M | 156.31M | -245.76M | -234.16M | -0.85 |
VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
아제너스 Stock (AGEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-06-06 | 개시 | Robert W. Baird | Outperform |
2023-02-28 | 재개 | H.C. Wainwright | Buy |
2022-09-28 | 개시 | SMBC Nikko | Outperform |
2021-12-16 | 개시 | H.C. Wainwright | Buy |
2019-11-19 | 재개 | B. Riley FBR | Buy |
2019-04-22 | 개시 | B. Riley FBR | Buy |
2016-10-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2016-10-27 | 재확인 | Maxim Group | Buy |
2016-03-11 | 업그레이드 | Maxim Group | Hold → Buy |
2015-12-16 | 개시 | Jefferies | Buy |
2015-10-27 | 다운그레이드 | Maxim Group | Buy → Hold |
2015-07-27 | 재확인 | MLV & Co | Buy |
2015-06-11 | 개시 | Oppenheimer | Outperform |
2015-01-12 | 재확인 | Maxim Group | Buy |
2015-01-09 | 재확인 | MLV & Co | Buy |
2015-01-09 | 재확인 | Maxim Group | Buy |
2014-12-19 | 재확인 | Maxim Group | Buy |
2014-05-08 | 재확인 | Maxim Group | Buy |
2014-03-14 | 재확인 | MLV & Co | Buy |
2013-10-08 | 재확인 | Maxim Group | Buy |
2012-01-05 | 개시 | William Blair | Outperform |
2011-12-01 | 개시 | Global Hunter Securities | Buy |
모두보기
아제너스 주식(AGEN)의 최신 뉴스
Agenus Inc. (NASDAQ:AGEN) Receives $10.00 Consensus Target Price from Analysts - MarketBeat
B. Riley Has Negative Outlook for Agenus FY2024 Earnings - MarketBeat
Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Agenus stock hits 52-week low at $2.56 amid market challenges - Investing.com Australia
Agenus Chooses Flex Databases for Enhanced Pharmacovigilance Solutions - openPR
Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Agenus Inc. (NASDAQ:AGEN) Short Interest Update - MarketBeat
William Blair Weighs in on Agenus' Q4 Earnings (NASDAQ:AGEN) - MarketBeat
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
Biotech Brass Misled Investors About Cancer Drugs, Suit Says - Law360
Agenus Top Brass Sued Over FDA Response to Cancer Drug Trial - Bloomberg Law
Agenus Inc. (NASDAQ:AGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Q3 2024 Agenus Inc Earnings Call - Cbainfo
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating F - GuruFocus.com
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ... - Yahoo Finance
Agenus Inc. Reports Progress in Immunotherapy Development - TipRanks
Agenus: Q3 Earnings Snapshot - Houston Chronicle
Agenus Reports Third Quarter 2024 Financial Results - citybiz
Agenus (AGEN) Q3 2024 Earnings Call Transcript - AOL
Agenus reports Q3 EPS ($3.08) vs ($3.29) last year - TipRanks
HC Wainwright Issues Pessimistic Forecast for Agenus (NASDAQ:AGEN) Stock Price - MarketBeat
Agenus Inc (AGEN) Q3 2024 Earnings: EPS Miss, Revenue at $25.1M vs. $61.48M Estimate - GuruFocus.com
Agenus Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Agenus Q3 Revenue Edges Up Despite Cash Concerns; BOT/BAL Shows Promise in Cancer Trials | AGEN Stock News - StockTitan
Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result - GuruFocus.com
Agenus stock hits 52-week low at $3.82 amid market challenges - Investing.com India
Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024 - Business Wire
Agenus to Showcase Breakthrough Cancer Immunotherapy Data at SITC 2024 Meeting | AGEN Stock News - StockTitan
Agenus (AGEN) Set to Announce Earnings on Tuesday - MarketBeat
AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Invest - GuruFocus.com
Agenus announces director Wiinberg's resignation and advisory role - Investing.com
AGENAgenus Inc. Latest Stock News & Market Updates - StockTitan
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire
Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - PR Newswire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - PR Newswire
Investors in Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - PR Newswire
Class Action Filed Against Agenus Inc. (AGEN)November 5, 2024 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - The Malaysian Reserve
AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - PR Newswire
Agenus stock hits 52-week low at $4.17 amid market challenges - Investing.com Australia
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Agenus to Contact Us to Have Their Losses Evaluated Today - GlobeNewswire Inc.
Agenus stock hits 52-week low at $4.17 amid market challenges By Investing.com - Investing.com South Africa
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities F - GuruFocus.com
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationAGEN - PR Newswire
Agenus Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
아제너스 (AGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):